Tandem reels in losses but misses revenue estimates in Q3

Shares in Tandem Diabetes Care (NSDQ:TNDM) rose today after the medical device maker reeled in its losses but missed sales estimates on Wall Street with its third quarter results.

The San Diego, Calif.-based company posted losses of -$16 million on sales of $23.7 million for the 3 months ended Sept. 30, for bottom-line growth of 46% on sales growth of 14.5% compared with the same period last year.

Get the full story at our sister site, Drug Delivery Business News.

The post Tandem reels in losses but misses revenue estimates in Q3 appeared first on MassDevice.

from MassDevice http://ift.tt/2hesBkA